Astera Labs, Inc. $ALAB Shares Sold by WINTON GROUP Ltd

WINTON GROUP Ltd decreased its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 33.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,252 shares of the company’s stock after selling 2,608 shares during the quarter. WINTON GROUP Ltd’s holdings in Astera Labs were worth $2,537,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Integrated Wealth Concepts LLC lifted its holdings in Astera Labs by 0.7% during the 2nd quarter. Integrated Wealth Concepts LLC now owns 7,006 shares of the company’s stock worth $3,384,000 after buying an additional 52 shares in the last quarter. IFP Advisors Inc grew its stake in shares of Astera Labs by 9.2% in the second quarter. IFP Advisors Inc now owns 4,241 shares of the company’s stock worth $2,048,000 after acquiring an additional 356 shares in the last quarter. Baird Financial Group Inc. acquired a new position in shares of Astera Labs in the second quarter worth $253,000. Arizona State Retirement System increased its position in shares of Astera Labs by 8.1% during the second quarter. Arizona State Retirement System now owns 39,042 shares of the company’s stock worth $18,858,000 after acquiring an additional 2,909 shares during the period. Finally, Nykredit A S acquired a new stake in shares of Astera Labs in the second quarter valued at $19,990,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ALAB has been the subject of a number of recent research reports. Bank of America lifted their target price on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Weiss Ratings restated a “hold (c)” rating on shares of Astera Labs in a report on Tuesday, August 18th. UBS Group reaffirmed a “neutral” rating and issued a $425.00 price target on shares of Astera Labs in a research report on Wednesday, August 5th. Needham & Company LLC lifted their price objective on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Finally, Citigroup reissued a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and an average target price of $348.33.

Insider Activity at Astera Labs

In other news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the completion of the sale, the director owned 253,863 shares in the company, valued at approximately $71,114,642.19. The trade was a 41.89% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan Dyckerhoff sold 3,505 shares of the company’s stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $274.96, for a total transaction of $963,734.80. Following the completion of the transaction, the director owned 50,456 shares of the company’s stock, valued at approximately $13,873,381.76. The trade was a 6.50% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 592,244 shares of company stock valued at $209,729,973 in the last quarter. Company insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $291.22 on Friday. The stock has a 50-day simple moving average of $316.60 and a 200-day simple moving average of $260.17. The stock has a market cap of $50.52 billion, a P/E ratio of 144.17 and a beta of 3.77. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business’s quarterly revenue was up 104.5% on a year-over-year basis. During the same quarter last year, the company earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.